ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,620Medicare Part D Prescriptions Filled, Including Refills

Rank: 138 out of 993

$492K Total Retail Price of All Prescriptions

Rank: 163 out of 993

449 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Kansas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 544 494 85 1 1
SIMVASTATIN 398 368 66 2 2
HYDROCODONE-ACETAMINOPHEN 376 355 80 S3 3 4
AMLODIPINE BESYLATE 358 353* 70 4 6
WARFARIN SODIUM 330 284 44 5 11
LISINOPRIL 301 259 64 6 3
POTASSIUM CHLORIDE 271 266* 43 7 10
HYDROCHLOROTHIAZIDE 268 263* 63 8 12
OMEPRAZOLE 234 213 42 9 5
ATENOLOL 213 208* 37 10 19
METOPROLOL SUCCINATE 206 184 35 11 17
FUROSEMIDE 181 164 32 12 7
DONEPEZIL HCL 167 167 23 13 31
SERTRALINE HCL 166 161* 25 14 21
PRAVASTATIN SODIUM 162 157* 34 15 20
GABAPENTIN 155 134 27 16 13
ALENDRONATE SODIUM 135 114 22 17 28
FLUTICASONE PROPIONATE 130 125* 40 18 34
LANTUS 127 114 16 19 52
ATORVASTATIN CALCIUM 124 119* 20 20 9
METOPROLOL TARTRATE 121 116* 21 21 14
NAMENDA 118 <11 <11 22 30
METFORMIN HCL 114 109* 23 23 8
LOVASTATIN 113 113 18 24 48
CLOPIDOGREL 110 110 14 25 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 92* 15 26 29
CITALOPRAM HBR 97 78 15 26 16
LOSARTAN-HYDROCHLOROTHIAZIDE 87 87 16 28 41
TRIAMTERENE-HCTZ 85 85 20 29 54
LORAZEPAM 85 80* 24 B 29 38
LOSARTAN POTASSIUM 82 77* 20 31 15
CRESTOR 79 74* 12 32 39
NOVOLOG 76 <11 <11 33 99
HUMALOG 76 76 14 33 127
FINASTERIDE 73 68* 14 35 91
PANTOPRAZOLE SODIUM 72 54 12 36 33
MELOXICAM 70 65* 16 37 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 65* 43 37 83
TERAZOSIN HCL 70 65* 13 37 116
RISPERIDONE 70 <11 <11 A 37 80
TAMSULOSIN HCL 66 61* 13 41 26
CARVEDILOL 65 54 13 42 27
ALLOPURINOL 63 63 12 43 32
OXYCODONE-ACETAMINOPHEN 60 29 11 S2 44 100
TRIAMCINOLONE ACETONIDE 60 55* 30 44 120
MIRTAZAPINE 58 58 12 46 42
ZETIA 57 <11 <11 47 70
DETROL LA 52 <11 <11 48 133
OXYCONTIN 52 <11 <11 S2 48 119
ROPINIROLE HCL 52 <11 <11 48 73
TRAMADOL HCL 52 47* 15 48 18
POLYETHYLENE GLYCOL 3350 50 <11 <11 52 43
OXYBUTYNIN CHLORIDE ER 50 <11 <11 52 126
ESCITALOPRAM OXALATE 50 <11 <11 52 50
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.